We bring together news, announcements and other updates from around Global Fund in this section. You can receive a notification every time a new update is published by using our really simple syndication (RSS) feed. See our RSS Feeds page for more information.
-
31 May 2022
47th Board Meeting Documents
-
20 May 2022
Refocusing C19RM Investments to Maximize Impact
The COVID-19 pandemic is evolving and so should C19RM investments. The Global Fund would like to support implementing countries to rethink how these funds need to be adapted to countries’ needs in a very dynamic pandemic context. -
20 May 2022
New Isoniazid/rifapentine and rifapentine generic for tuberculosis (TB) prevention recently recommended for use by ERP
The following products have been recommended for use by the Expert Review Panel (ERP): Rifapentine 300mg tablets Al/Al strip pack manufactured by Lupin, India; Rifapentine/Isoniazid 300/300mg Al/Al strip pack manufactured by Lupin, India -
20 May 2022
External Quality Assessment: Highest Possible Results for OIG Audit and Investigation Units
-
10 May 2022
Pandemic Preparedness and Response - Thematic Report
-
04 May 2022
COVID-19 Clinical Therapeutics
In this operational update, we would like to give you an update on COVID-19 testing and therapeutics that can be currently supported through the Global Fund’s COVID-19 Response Mechanism (C19RM), following WHO guidelines. -
03 May 2022
Global Fund Appoints Susie Rhee as General Counsel and Head of the Legal & Governance Department
The Global Fund is pleased to announce the appointment of Susie Rhee as the new General Counsel and Head of the Legal & Governance Department. -
29 April 2022
Conflicts, Crises and Displaced People: How the Global Fund Works in Challenging Operating Environments - Thematic Report
-
21 April 2022
Update on the C19RM Health Product Management Template (HPMT)
The C19RM Health Products Management Template has been updated to include TB cartridges (GeneXpert and Truenat). Principal Recipients can now procure these health products to support integrated testing of tuberculosis and COVID-19 under C19RM 2021 fi... -
08 April 2022
Opportunity for Evaluation of Diagnostic Products
The Global Fund and Unitaid are inviting manufacturers of diagnostic products to submit an Expression of Interest (EoI) to have their products evaluated by the Expert Review Panel for Diagnostics (ERPD). This evaluation will focus particularly on dia...